Prestige Consumer Healthcare
PBH
$64.65
Share price
-0.51%
Change (1 day)
9.15%
Change (1 year)
Categories
Prestige Consumer Healthcare (PBH) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $1.73 B
According to Prestige Consumer Healthcare's latest financial reports the company's total liabilities are $1.73 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Prestige Consumer Healthcare - Total liabilities on balance sheet (from 2004 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-03-31 | $1.90 B | -8.91% |
| 2022-03-31 | $2.09 B | 1.07% |
| 2021-03-31 | $2.07 B | -11.61% |
| 2020-03-31 | $2.34 B | -0.1% |
| 2019-03-31 | $2.34 B | -9.17% |
| 2018-03-31 | $2.58 B | -16.41% |
| 2017-03-31 | $3.08 B | 40.12% |
| 2016-03-31 | $2.20 B | 9.44% |
| 2015-03-31 | $2.01 B | 63.46% |
| 2014-03-31 | $1.23 B | -2.34% |
| 2013-03-31 | $1.26 B | -6.91% |
| 2012-03-31 | $1.35 B | 95.02% |
| 2011-03-31 | $0.69 B | 50.34% |
| 2010-03-31 | $0.46 B | -8.81% |
| 2009-03-31 | $0.50 B | -11.07% |
| 2008-03-31 | $0.57 B | -7.77% |
| 2007-03-31 | $0.61 B | -1.77% |
| 2006-03-31 | $0.62 B | 2.39% |
| 2005-03-31 | $0.61 B | 207.1% |
| 2004-03-31 | $0.20 B | 103.79% |
| 2003-03-31 | $98.19 M | -14.83% |
| 2002-03-31 | $0.11 B | 9.54% |
| 2001-03-31 | $0.10 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $101.94 B | 5,761.73% | 🇺🇸 USA |
 Procter & Gamble PG | $69.26 B | 3,882.62% | 🇺🇸 USA |
 Novartis NVS | $54.57 B | 3,038.15% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 7,789.52% | 🇺🇸 USA |
 Abbott Laboratories ABT | $34.38 B | 1,877.20% | 🇺🇸 USA |
 Clorox CLX | $5.55 B | 219.12% | 🇺🇸 USA |
 CVS Health CVS | $175.59 B | 9,996.31% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $57.22 B | 3,190.29% | 🇬🇧 UK |
 Rite Aid
RAD | $9.09 B | 422.79% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | $0.38 B | -77.92% | 🇮🇱 Israel |